Haemonetics Corp. Secures New Credit for Strategic Growth

TipRanksMay 2 04:23

Getting In Cheap On Haemonetics Corporation (NYSE:HAE) Might Be Difficult

With a price-to-earnings (or "P/E") ratio of 33.8x Haemonetics Corporation (NYSE:HAE) may be sending very bearish signals at the moment, given that almost half of all companies in the United States ha

Simply Wall StApr 17 22:09

Haemonetics Is Maintained at Outperform by Barrington Research

Haemonetics Is Maintained at Outperform by Barrington Research

Dow JonesApr 12 22:53

Barrington Research: Maintaining the Haemonetics (HAE.US) rating, adjusted from better than market to better than market rating, and adjusted the target price from $105.00 to $105.00.

Barrington Research: Maintaining the Haemonetics (HAE.US) rating, adjusted from better than market to better than market rating, and adjusted the target price from $105.00 to $105.00.

Zhitong FinanceApr 12 22:50

Barrington Research Maintains Outperform on Haemonetics, Maintains $105 Price Target

Barrington Research analyst Michael Petusky maintains Haemonetics (NYSE:HAE) with a Outperform and maintains $105 price target.

BenzingaApr 12 22:43

Haemonetics Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/12/2024 22.12% Barrington Research $105 → $105 Maintains Outperform 02/13/2024 22.12% Barrington Resear

BenzingaApr 12 22:42